Zhejiang Jingxin Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 2.64%

Zhejiang Jingxin Pharmaceutical Co Ltd (002020) has an Asset Resilience Ratio of 2.64% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 002020 total debt and obligations for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥210.53 Million

≈ $30.81 Million USD Cash + Short-term Investments

Total Assets

CN¥7.98 Billion

≈ $1.17 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2001–2024)

This chart shows how Zhejiang Jingxin Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. See 002020 net asset value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Zhejiang Jingxin Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Zhejiang Jingxin Pharmaceutical Co Ltd stock valuation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥210.53 Million	2.64%
Total Liquid Assets	CN¥210.53 Million	2.64%

Asset Resilience Insights

Limited Liquidity: Zhejiang Jingxin Pharmaceutical Co Ltd maintains only 2.64% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Zhejiang Jingxin Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Zhejiang Jingxin Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Jiangsu Hengrui Medicine Co Ltd SHG:600276	Drug Manufacturers - Specialty & Generic	0.16%
Aspen Pharmacare Holdings Ltd JSE:APN	Drug Manufacturers - Specialty & Generic	6.67%
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Tibet Rhodiola Pharmaceutical Holding Co SHG:600211	Drug Manufacturers - Specialty & Generic	21.16%
Dezhan HealthCare Co Ltd SHE:000813	Drug Manufacturers - Specialty & Generic	0.29%
Chongqing Pharscin Pharmaceutical Co Ltd SHE:002907	Drug Manufacturers - Specialty & Generic	14.54%
Jiangsu Jibeier Pharmaceutical Co Ltd SHG:688566	Drug Manufacturers - Specialty & Generic	5.72%
Bide Pharmatech Co. Ltd. A SHG:688073	Drug Manufacturers - Specialty & Generic	18.22%

Annual Asset Resilience Ratio for Zhejiang Jingxin Pharmaceutical Co Ltd (2001–2024)

The table below shows the annual Asset Resilience Ratio data for Zhejiang Jingxin Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	9.76%	CN¥827.66 Million ≈ $121.11 Million	CN¥8.48 Billion ≈ $1.24 Billion	+7.87pp
2023-12-31	1.89%	CN¥150.96 Million ≈ $22.09 Million	CN¥7.99 Billion ≈ $1.17 Billion	-3.09pp
2022-12-31	4.98%	CN¥366.89 Million ≈ $53.69 Million	CN¥7.36 Billion ≈ $1.08 Billion	-1.60pp
2021-12-31	6.58%	CN¥422.40 Million ≈ $61.81 Million	CN¥6.42 Billion ≈ $938.77 Million	-14.22pp
2020-12-31	20.80%	CN¥1.18 Billion ≈ $172.50 Million	CN¥5.67 Billion ≈ $829.15 Million	-13.83pp
2019-12-31	34.64%	CN¥1.95 Billion ≈ $285.11 Million	CN¥5.63 Billion ≈ $823.13 Million	+5.69pp
2018-12-31	28.95%	CN¥1.45 Billion ≈ $211.45 Million	CN¥4.99 Billion ≈ $730.45 Million	-4.60pp
2017-12-31	33.54%	CN¥1.65 Billion ≈ $240.72 Million	CN¥4.90 Billion ≈ $717.61 Million	+14.70pp
2016-12-31	18.84%	CN¥620.00 Million ≈ $90.73 Million	CN¥3.29 Billion ≈ $481.52 Million	+6.03pp
2015-12-31	12.81%	CN¥376.65 Million ≈ $55.12 Million	CN¥2.94 Billion ≈ $430.20 Million	-4.04pp
2014-12-31	16.86%	CN¥348.00 Million ≈ $50.92 Million	CN¥2.06 Billion ≈ $302.12 Million	+16.85pp
2012-12-31	0.00%	CN¥50.70K ≈ $7.42K	CN¥1.30 Billion ≈ $190.37 Million	0.00pp
2011-12-31	0.01%	CN¥73.61K ≈ $10.77K	CN¥1.19 Billion ≈ $174.51 Million	-3.27pp
2001-12-31	3.28%	CN¥5.00 Million ≈ $731.66K	CN¥152.50 Million ≈ $22.32 Million	--

pp = percentage points

About Zhejiang Jingxin Pharmaceutical Co Ltd

SHE:002020 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.90 Billion

CN¥12.96 Billion CNY

Market Cap Rank

#6527 Global

#1509 in China

Share Price

CN¥15.05

Change (1 day)

+0.20%

52-Week Range

CN¥12.90 - CN¥21.63

All Time High

CN¥25.17